A carregar...
Thromboinflammation response to tocilizumab in COVID‐19
BACKGROUND: Coronavirus disease‐19 (COVID‐19) spans a wide spectrum of illness. Severe cases of COVID‐19 can manifest inflammation in organs other than the lung, in tissues not known to support viral replication, and also in a hypercoagulable state. These observations have suggested that severe acut...
Na minha lista:
| Publicado no: | Res Pract Thromb Haemost |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7537313/ https://ncbi.nlm.nih.gov/pubmed/33043232 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12436 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|